The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the U.S. over the next five years, amid ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

Even though there is currently inflation of goods, healthcare rising, and other basic amenities, it has been forecasted the ...

Shares in South Africa's Aspen Pharmacare dropped more than 30% on Wednesday, a day after the company issued a profit warning ...

One of the company’s subsidiaries, Lupin Diagnostics Limited, has become the first 100 per cent NABL accredited company in ...

"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...

The letter was sent by around 30 CEOs of some of the largest pharmaceutical companies in the world. The companies - including Pfizer, Eli Lilly and AstraZeneca - said they face cost disadvantages ...

“Factors influencing this shift include the U.S. government emphasizing reduced reliance on foreign suppliers; major pharmaceutical companies making … U.S. expansions; and policy incentives ...